Anavex Life Sciences (AVXL) Receivables - Other (2022 - 2025)
Anavex Life Sciences recorded quarterly Receivables - Other of $700000.0 in Q4 2025, little changed quarter-over-quarter from $700000.0 in Q3 2025, and down 70.83% year-over-year from $2.4 million in Q4 2024.
Anavex Life Sciences' Receivables - Other history runs 4 years deep, the most recent figure standing at $700000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 70.83% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (down 70.83% YoY), while the FY2025 annual figure was $700000.0, down 69.57% from the prior year.
- Receivables - Other came in at $700000.0 for Q4 2025 at Anavex Life Sciences, roughly flat from $700000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.9 million in Q3 2022 to a low of $500000.0 in Q1 2025.
- A 4-year average of $1.6 million and a median of $1.5 million in 2024 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other slipped 8.0% in 2024 and plunged 70.83% in 2025, its largest moves.
- Anavex Life Sciences' Receivables - Other stood at $2.9 million in 2022, then slipped by 13.79% to $2.5 million in 2023, then declined by 4.0% to $2.4 million in 2024, then sank by 70.83% to $700000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $700000.0, $700000.0, and $600000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 2.40 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Sep 30, 2022 | 2.90 Mn |